US Patent Issued to LTS Lohmann Therapie-Systeme, Novaliq on May 27 for "Use of semi-fluorinated alkanes in transdermal therapeutic systems" (German, Swiss Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,977, issued on May 27, was assigned to LTS Lohmann Therapie-Systeme AG (Andernach, Germany) and Novaliq GmbH (Heidelberg, Germany).

"Use of semi-fluorinated alkanes in transdermal therapeutic systems" was invented by Sandra Wiedersberg (Steigra, Germany), Bernhard Gunther (Dossenheim, Germany) and Dieter Scherer (Laufen, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the use of semi-fluorinated alkanes, in particular mixed with ethanol, as solubilising agents, permeation promoters and/or enhancers for lipophilic and/or poorly skin-permeable pharmaceutical agents that are administered via a transdermal therapeutic...